These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18418552)

  • 1. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
    Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
    J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
    Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
    Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
    Barresi V; Alafaci C; Salpietro F; Tuccari G
    Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 immunoreactivity in meningiomas.
    Milenković S; Marinkovic T; Jovanovic MB; Djuricic S; Berisavac II; Berisavac I
    Cell Mol Neurobiol; 2008 Sep; 28(6):907-13. PubMed ID: 18379871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
    Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
    Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.
    Yang SY; Xu GM
    J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP; Caemaert J; De Ridder L
    In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk.
    Barresi V; Branca G; Caffo M; Tuccari G
    J Neurooncol; 2015 Mar; 122(1):87-95. PubMed ID: 25563814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
    Hakin-Smith V; Battersby RD; Maltby EL; Timperley WR; Royds JA
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):40-9. PubMed ID: 11299001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor.
    Bitzer M; Opitz H; Popp J; Morgalla M; Gruber A; Heiss E; Voigt K
    Acta Neurochir (Wien); 1998; 140(4):333-40. PubMed ID: 9689324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
    Pfister C; Pfrommer H; Tatagiba MS; Roser F
    Br J Cancer; 2012 Nov; 107(10):1702-13. PubMed ID: 23047550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of androgen receptor in meningiomas.
    Chen J; Chen G
    J Tongji Med Univ; 2001; 21(2):140-2. PubMed ID: 11523220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.